Aiming to further establish the concept of ZHX2/LPL axis in NAFLD–HCC progression, ZHX2 (AAV-ZHX2) and LPL (AAV-LPL) were introduced into STZ–HFD mice either separately or simultaneously. Here, ZHX2 is linked to metabolic dysfunction-associated steatotic liver disease.